High‑Dose Flu Shot Linked to Sharply Lower Alzheimer’s Risk in Seniors

A new observational study led by researchers at the University of Texas Health Science Center at Houston finds that adults 65 and older who received a high‑dose influenza vaccine had a markedly lower risk of developing Alzheimer’s disease than those who got a standard‑dose shot or remained unvaccinated. Analyzing medical records from nearly 200,000 older adults, the team reports that the quadruple‑strength vaccine was associated with an almost 55% lower Alzheimer’s risk compared with no flu vaccination and clearly outperformed standard‑dose protection, with the effect especially pronounced in women. The work builds on earlier research by lead author Dr. Paul Schulz that linked any flu vaccination to about a 40% reduction in Alzheimer’s risk, but this is the first to focus specifically on dose strength. Outside experts, including Fox News medical contributor Dr. Marc Siegel, stress the study shows correlation rather than proof that the shot itself prevents Alzheimer’s and suggest the mechanism may involve immune modulation and reduced inflammation rather than any direct effect on brain cells. Because high‑dose flu vaccines are already recommended by CDC for Americans over 65, the findings are likely to intensify debate in medical circles and online about whether aggressive influenza vaccination in seniors should be considered part of broader dementia‑prevention strategies, while skeptics warn about over‑interpreting retrospective data that may be confounded by healthier behaviors among people who seek high‑dose shots.